UCL logo

UCL Discovery

UCL home » Library Services » Electronic resources » UCL Discovery

Browse by UCL Departments and Centres

Up a level
Export as [feed] RSS 2.0 [feed] RSS 1.0 [feed] Atom
Group by: Author | Type
Jump to: C | E | F | G | H | K | L | N | P | S | T | W
Number of items: 31.

C

Campbell, WB; Aitken, M; Tooke, JE; (2002) Expectations for the skills of final year medical students in examining lower limb arteries and veins. EUR J VASC ENDOVASC , 23 (3) 270 - 271. 10.1053/ejvs.2002.1596.

E

Eiser, JR; Eiser, C; Riazi, A; Hammersley, S; Tooke, JE; (2002) Interpretations of risk and expectations of change among individuals with types 1 and 2 diabetes. J HEALTH PSYCHOL , 7 (6) 701 - 711.

F

Fegan, PG; Macleod, KM; Tooke, JE; Shore, AC; (2002) n-3 NEFA: vascular implications. EUR HEART J , 23 (3) 185 - 187. 10.1053/euhj.2001.2945.

G

Gooding, KM; Tooke, JE; Shore, AC; (2002) Assessment of microvascular filtration coefficent during early and late phase of the menstrual cycle in females not taking the oral contraceptive pill. J PHYSIOL-LONDON , 539 85P - 86P.

H

Hannemann, MM; Liddell, WG; Shore, AC; Clark, PM; Tooke, JE; (2002) Vascular function in women with previous gestational diabetes mellitus. J VASC RES , 39 (4) 311 - 319.

Hull, RD; Kakkar, AK; Marder, VJ; Pineo, GF; Goldberg, MM; Raskob, GE; PROTECT Trial,; (2002) Oral SNAC-heparin vs. enoxaparin for preventing venous thromboembolism following total hip replacement. In: BLOOD. (pp. 148A - 149A). AMER SOC HEMATOLOGY

K

Kakkar, AK; Kadziola, Z; Williamson, RCN; Levine, MN; Low, V; Lemoine, NR; Fragmin Adv Malignancy Outcome,; (2002) Low molecular weight heparin (LMWH) therapy and survival in advanced cancer. In: BLOOD. (pp. 148A - 148A). AMER SOC HEMATOLOGY

Kakkar, AK; Levine, MN; (2002) Introduction: building on a heritage in thrombosis - perspectives in cancer care. CANCER TREAT REV , 28 (3) 131 - 131. 10.1016/S0305-7372(02)00039-7.

Kakkar, AK; Levine, MN; Prandoni, P; Lee, AY; Rasmussen, MS; Kuter, D; (2002) What is the role for antithrombotics in cancer care? Interactive session with panel discussion. CANCER TREAT REV , 28 (3) 157 - 159. 10.1016/S0305-7372(02)00045-2.

Kakkar, AK; Samama, MM; (2002) Introduction - Uncharted territories in thrombosis care: Expanding into new areas. SEMIN THROMB HEMOST , 28 1 - 1.

Khorsandi, SE; Kakkar, AK; (2002) Inhibition of tumour xenograft growth by targeting hypoxic gene expression. BRIT J SURG , 89 (5) 635 - 636.

Kuenen, BC; Levi, M; Meijers, JCM; Kakkar, AK; van Hinsbergh, VWM; Kostense, PJ; ... Hoekman, K; + view all (2002) Analysis of coagulation cascade and endothelial cell activation during inhibition of vascular endothelial growth factor/vascular endothelial growth factor receptor pathway in cancer patients. ARTERIOSCL THROM VAS , 22 (9) 1500 - 1505. 10.1161/01.ATV.0000030186.66672.36.

L

Levine, MN; Lee, AY; Baker, RI; Bowden, C; Kakkar, AK; Prins, M; ... CLOT Investigators,; + view all (2002) A Randomized trial of long term dalteparin low molecular weight heparin (LMWH) versus oral anticoagulant (OA) therapy in cancer patients with venous thromboembolism (VTE). In: BLOOD. (pp. 82A - 82A). AMER SOC HEMATOLOGY

Lindsey, B; Sneyd, R; Tooke, JE; Wilkins, DC; Ashley, S; (2002) Critically ischaemic feet harbour an endothelium mediated but nitric oxide independent pathway that shunts blood away from the nutritional microcirculation. BRIT J SURG , 89 100 - 100.

N

Nabuurs-Franssen, MH; Houben, AJHM; Tooke, JE; Schaper, NC; (2002) The effect of polyneuropathy on foot microcirculation in Type II diabetes. DIABETOLOGIA , 45 (8) 1164 - 1171. 10.1007/s00125-002-0872-z.

Nash, GF; Chopada, A; Eccles, S; Swift, RI; Sculley, MF; Kakkar, AK; (2002) Endostatin is released from human platelets. BRIT J SURG , 89 (5) 662 - 662.

Nash, GF; Chopada, A; Kakkar, AK; (2002) Endostatin in circulating blood cells. BRIT J CANCER , 86 S97 - S97.

Nash, GF; Chopada, A; Patel, H; Kakkar, AK; (2002) Stored blood products stimulate cancer growth. BRIT J SURG , 89 19 - 19.

Nash, GF; Turner, LF; Scully, MF; Kakkar, AK; (2002) Platelets and cancer. LANCET ONCOL , 3 (7) 425 - 430.

P

Patel, HB; Lall, DG; Nasir, FA; Kakkar, AK; (2002) Blood products have increased angiogenesis stimulating effects following storage. In: BLOOD. (pp. 282A - 283A). AMER SOC HEMATOLOGY

Patel, HB; Nasir, FA; Nash, GF; Kakkar, AK; (2002) The increase in pro-angiogenic potential of recipient blood following blood transfusion. In: BLOOD. (pp. 26A - 26A). AMER SOC HEMATOLOGY

S

Sampson, MT; Kakkar, AK; (2002) Coagulation proteases and human cancer. BIOCHEMICAL SOCIETY TRANSACTIONS , 30 201 - 207.

Satchell, SC; Anderson, KL; Tooke, JE; Bates, DO; Mathieson, PW; (2002) Angiopoietin I increases the integrity of human glomerular endothelial cell monolayers. J AM SOC NEPHROL , 13 496A - 496A.

Satchell, SC; Harper, SJ; Tooke, JE; Kerjaschki, D; Saleem, MA; Mathieson, PW; (2002) Human podocytes express angiopoietin 1, a potential regulator of glomerular vascular endothelial growth factor. J AM SOC NEPHROL , 13 (2) 544 - 550.

Shore, AC; Evans, JC; Frayling, TM; Clark, PM; Lee, BC; Horikawa, Y; ... Tooke, JE; + view all (2002) Association of the calpain-10 gene with microvascular function. DIABETOLOGIA , 45 (6) 899 - 904. 10.1007/s00125-002-0847-0.

T

Thodiyil, P; Kakkar, AK; (2002) Can low-molecular-weight heparins improve outcome in patients with cancer? CANCER TREATMENT REVIEWS , 28 (3) 151 - 155. 10.1016/S0305-7372(02)00040-3.

Thodiyil, PA; Kakkar, AK; (2002) Variation in relative risk of venous thromboembolism in different cancers. THROMB HAEMOSTASIS , 87 (6) 1076 - 1077.

Tooke, J; (2002) Students need to resist personality conformity. BRIT MED J , 325 (7366) 677 - 677.

W

Walsh, DC; Kakkar, AK; (2002) Thromboprophylaxis. J NEUROSURG , 96 (4) 806 - 807.

Whatmore, JL; Swann, E; Barraja, P; Newsome, JJ; Bunderson, M; Beall, HD; ... Moody, CJ; + view all (2002) Comparative study of isoflavone, quinoxaline and oxindole families of anti-angiogenic agents. Angiogenesis , 5 (1-2) 45 - 51.

White, MP; Riazi, A; Eiser, C; Hammersley, S; Eiser, JR; MacLeod, K; Tooke, JE; (2002) Interpreting the risks of diabetic renal disease: Perspectives of those most at risk. PSYCHOL HEALTH , 17 (1) 33 - 50. 10.1080/08870440290001511.

This list was generated on Sun Oct 19 01:44:15 2014 BST.